Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

SC Pharmaceuticals Inc (SCPH)

SC Pharmaceuticals Inc (SCPH)
3.04 +0.03 (+1.00%) 10:15 ET [NASDAQ]
3.02 x 400 3.05 x 200
Realtime by (Cboe BZX)
3.02 x 400 3.05 x 200
Realtime - - (-) -
Quote Overview for Fri, Mar 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.92
Day High
3.07
Open 2.97
Previous Close 3.01 3.01
Volume 104,715 104,715
Avg Vol 591,276 591,276
Stochastic %K 41.44% 41.44%
Weighted Alpha -38.12 -38.12
5-Day Change +0.04 (+1.32%) +0.04 (+1.32%)
52-Week Range 2.75 - 5.65 2.75 - 5.65
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 150,620
  • Shares Outstanding, K 50,040
  • Annual Sales, $ 13,590 K
  • Annual Income, $ -54,810 K
  • EBIT $ -64 M
  • EBITDA $ -64 M
  • 60-Month Beta 0.40
  • Price/Sales 4.19
  • Price/Cash Flow N/A
  • Price/Book 4.95

Options Overview Details

View History
  • Implied Volatility 110.97% ( -41.06%)
  • Historical Volatility 45.05%
  • IV Percentile 42%
  • IV Rank 22.13%
  • IV High 451.74% on 02/03/25
  • IV Low 14.11% on 06/20/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 31
  • Volume Avg (30-Day) 184
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 4,660
  • Open Int (30-Day) 3,819

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.24
  • Number of Estimates 1
  • High Estimate -0.24
  • Low Estimate -0.24
  • Prior Year -0.36
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.75 +11.64%
on 03/10/25
Period Open: 3.25
3.52 -12.78%
on 03/03/25
-0.18 (-5.54%)
since 02/21/25
3-Month
2.75 +11.64%
on 03/10/25
Period Open: 3.39
3.87 -20.57%
on 02/13/25
-0.32 (-9.44%)
since 12/20/24
52-Week
2.75 +11.64%
on 03/10/25
Period Open: 5.38
5.65 -45.66%
on 09/16/24
-2.31 (-42.94%)
since 03/21/24

Most Recent Stories

More News
scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

SCPH : 3.04 (+1.00%)
scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025

SCPH : 3.04 (+1.00%)
scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

SCPH : 3.04 (+1.00%)
scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences

SCPH : 3.04 (+1.00%)
scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

SCPH : 3.04 (+1.00%)
scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

SCPH : 3.04 (+1.00%)
2 "Strong Buy"-Rated Biotech Stocks With 303% to 446% Upside Potential

While the upside is appealing, penny stocks carry some risks.

TCRX : 1.5900 (-1.24%)
$SPX : 5,613.02 (-0.88%)
SCPH : 3.04 (+1.00%)
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update

SCPH : 3.04 (+1.00%)
scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

SCPH : 3.04 (+1.00%)
scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024

SCPH : 3.04 (+1.00%)

Business Summary

scPharmaceuticals, Inc., is a biopharmaceutical company. It engaged in developing pharmaceutical products for subcutaneous delivery. The Company's pipeline programs include: scFurosemide lead product candidate, Furoscix, consists of its proprietary subcutaneous formulation of furosemide delivered via...

See More

Key Turning Points

3rd Resistance Point 3.46
2nd Resistance Point 3.32
1st Resistance Point 3.17
Last Price 3.04
1st Support Level 2.88
2nd Support Level 2.74
3rd Support Level 2.59

See More

52-Week High 5.65
Fibonacci 61.8% 4.54
Fibonacci 50% 4.20
Fibonacci 38.2% 3.86
Last Price 3.04
52-Week Low 2.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals